Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications

Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation

(2012) Darius Ghaderi et al.   Biotechnology & Genetic Engineering Reviews

World Bispecific Antibody Summit, September 27–28, 2011, Boston, MA

(2012) Eugen Dhimolea et al.   mAbs

Improved stability of multivalent antibodies containing the human collagen XV trimerization domain

(2012) Ángel M. Cuesta et al.   mAbs

Factory neovessels: engineered human blood vessels secreting therapeutic proteins as a new drug delivery system

(2010) M Compte et al.   GENE THERAPY

Catumaxomab

(2010) Rolf Linke et al.   mAbs

Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli

(2009) Juanni Liu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Bispecific T-Cell Engaging Antibodies for Cancer Therapy

(2009) P. A. Baeuerle et al.   CANCER RESEARCH

In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences

(2009) Ángel M. Cuesta et al.   PLoS One

Lymphocyte Display: A Novel Antibody Selection Platform Based on T Cell Activation

(2009) Vanesa Alonso-Camino et al.   PLoS One

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody

(2008) R. Bargou et al.   SCIENCE

Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds

(2008) Marta Compte et al.   STEM CELLS